Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Forge Biologics
Podcast
Inside the industry’s read on FDA’s PreCheck
This week on “The Top Line,” we cover what’s known about FDA’s PreCheck and the parts of the plan that could have the biggest impact on manufacturers.
Ayla Ellison
,
Fraiser Kansteiner
Nov 7, 2025 11:44am
FDA drafts new policies to boost US drug production
Oct 3, 2025 3:52pm
Ajinomoto cuts staff in California to streamline manufacturing
Aug 12, 2024 8:51am
CDMO Ajinomoto shells out $620M in Forge Biologics buy
Nov 13, 2023 11:09am
Forge blazes into collaboration to bolster AAV gene therapies
Oct 12, 2023 9:25am
Forge fires up gene therapy production partnership with Life Bio
May 9, 2023 9:05am
